Enterprise record

ANAVEX LIFE SCIENCES CORP. logo

ANAVEX LIFE SCIENCES CORP.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:121f7b6f-a4b4-45f7-98f2-23c1a8e32884Version: public-1As of: unavailable

11 published Claims3 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 3 claims
    • Legal Name: ANAVEX LIFE SCIENCES CORP. · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026

  2. ANAVEX LIFE SCIENCES CORP. DEF 14A 2025-04-25

    sec proxy · Source published: Apr 25, 2025 · Retrieved: Apr 24, 2026

    Supports 6 claims
    • Leadership Role: Athanasios Skarpelos: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Christopher Missling, PhD: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Claus van der Velden, PhD: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Jiong Ma, PhD: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Peter Donhauser, D.O.: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Steffen Thomas, PhD: Director · Claim reviewed: Sep 28, 2026

  3. AVXL 10-K executive officers

    sec filing · Source published: Nov 25, 2025 · Retrieved: May 14, 2026

    Supports 2 claims
    • Leadership Role: Christopher Missling: Chief Executive Officer (Principal Executive Officer) and Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Sandra Boenisch: Principal Financial Officer and Treasurer (Principal Accounting Officer) · Claim reviewed: Sep 28, 2026